363 related articles for article (PubMed ID: 29867927)
21. Exercise rescues the immune response fine-tuned impaired by peroxisome proliferator-activated receptors γ deletion in macrophages.
Silveira LS; Batatinha HAP; Castoldi A; Câmara NOS; Festuccia WT; Souza CO; Rosa Neto JC; Lira FS
J Cell Physiol; 2019 Apr; 234(4):5241-5251. PubMed ID: 30238979
[TBL] [Abstract][Full Text] [Related]
22. Maresin1 Promotes M2 Macrophage Polarization Through Peroxisome Proliferator-Activated Receptor-γ Activation to Expedite Resolution of Acute Lung Injury.
Qiao N; Lin Y; Wang Z; Chen JY; Ge YY; Yao SL; Gong J
J Surg Res; 2020 Dec; 256():584-594. PubMed ID: 32805581
[TBL] [Abstract][Full Text] [Related]
23. Treatment in vitro with PPARα and PPARγ ligands drives M1-to-M2 polarization of macrophages from T. cruzi-infected mice.
Penas F; Mirkin GA; Vera M; Cevey Á; González CD; Gómez MI; Sales ME; Goren NB
Biochim Biophys Acta; 2015 May; 1852(5):893-904. PubMed ID: 25557389
[TBL] [Abstract][Full Text] [Related]
24. Amniotic membrane induces peroxisome proliferator-activated receptor-γ positive alternatively activated macrophages.
Bauer D; Hennig M; Wasmuth S; Baehler H; Busch M; Steuhl KP; Thanos S; Heiligenhaus A
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):799-810. PubMed ID: 22222510
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator-activated receptor γ deficiency in T cells accelerates chronic rejection by influencing the differentiation of CD4+ T cells and alternatively activated macrophages.
Huang X; Ren L; Ye P; Cheng C; Wu J; Wang S; Sun Y; Liu Z; Xie A; Xia J
PLoS One; 2014; 9(11):e112953. PubMed ID: 25383620
[TBL] [Abstract][Full Text] [Related]
26. Macrophage CGI-58 Attenuates Inflammatory Responsiveness via Promotion of PPARγ Signaling.
Yang D; Chen H; Zeng X; Xie P; Wang X; Liu C
Cell Physiol Biochem; 2016; 38(2):696-713. PubMed ID: 26872126
[TBL] [Abstract][Full Text] [Related]
27. Nuciferine Inhibits Proinflammatory Cytokines via the PPARs in LPS-Induced RAW264.7 Cells.
Zhang C; Deng J; Liu D; Tuo X; Yu Y; Yang H; Wang N
Molecules; 2018 Oct; 23(10):. PubMed ID: 30360404
[TBL] [Abstract][Full Text] [Related]
28. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism.
Yu Y; Correll PH; Vanden Heuvel JP
Biochim Biophys Acta; 2002 Apr; 1581(3):89-99. PubMed ID: 12020636
[TBL] [Abstract][Full Text] [Related]
29. Leukocyte Overexpression of Intracellular NAMPT Attenuates Atherosclerosis by Regulating PPARγ-Dependent Monocyte Differentiation and Function.
Bermudez B; Dahl TB; Medina I; Groeneweg M; Holm S; Montserrat-de la Paz S; Rousch M; Otten J; Herias V; Varela LM; Ranheim T; Yndestad A; Ortega-Gomez A; Abia R; Nagy L; Aukrust P; Muriana FJG; Halvorsen B; Biessen EAL
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1157-1167. PubMed ID: 28408371
[TBL] [Abstract][Full Text] [Related]
30. Irisin drives macrophage anti-inflammatory differentiation via JAK2-STAT6-dependent activation of PPARγ and Nrf2 signaling.
Tu Y; Liu J; Kong D; Guo X; Li J; Long Z; Peng J; Wang Z; Wu H; Liu P; Liu R; Yu W; Li W
Free Radic Biol Med; 2023 May; 201():98-110. PubMed ID: 36940733
[TBL] [Abstract][Full Text] [Related]
31. The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD.
Lea S; Plumb J; Metcalfe H; Spicer D; Woodman P; Fox JC; Singh D
Eur Respir J; 2014 Feb; 43(2):409-20. PubMed ID: 23794466
[TBL] [Abstract][Full Text] [Related]
32. Atorvastatin promotes human monocyte differentiation toward alternative M2 macrophages through p38 mitogen-activated protein kinase-dependent peroxisome proliferator-activated receptor γ activation.
Zhang O; Zhang J
Int Immunopharmacol; 2015 May; 26(1):58-64. PubMed ID: 25794645
[TBL] [Abstract][Full Text] [Related]
33. Effect of an acute moderate-exercise session on metabolic and inflammatory profile of PPAR-α knockout mice.
Silveira LS; Pimentel GD; Souza CO; Biondo LA; Teixeira AAS; Lima EA; Batatinha HAP; Rosa Neto JC; Lira FS
Cell Biochem Funct; 2017 Dec; 35(8):510-517. PubMed ID: 29063619
[TBL] [Abstract][Full Text] [Related]
34. The In Vitro and In Vivo Anti-Inflammatory Effects of a Phthalimide PPAR-γ Agonist.
Su M; Cao J; Huang J; Liu S; Im DS; Yoo JW; Jung JH
Mar Drugs; 2017 Jan; 15(1):. PubMed ID: 28054961
[TBL] [Abstract][Full Text] [Related]
35. FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages.
Boss M; Kemmerer M; Brüne B; Namgaladze D
Atherosclerosis; 2015 Jun; 240(2):424-30. PubMed ID: 25897794
[TBL] [Abstract][Full Text] [Related]
36. Activation of macrophage peroxisome proliferator-activated receptor-gamma by diclofenac results in the induction of cyclooxygenase-2 protein and the synthesis of anti-inflammatory cytokines.
Ayoub SS; Botting RM; Joshi AN; Seed MP; Colville-Nash PR
Mol Cell Biochem; 2009 Jul; 327(1-2):101-10. PubMed ID: 19219624
[TBL] [Abstract][Full Text] [Related]
37. Protein arginine methyltransferase 1 modulates innate immune responses through regulation of peroxisome proliferator-activated receptor γ-dependent macrophage differentiation.
Tikhanovich I; Zhao J; Olson J; Adams A; Taylor R; Bridges B; Marshall L; Roberts B; Weinman SA
J Biol Chem; 2017 Apr; 292(17):6882-6894. PubMed ID: 28330868
[TBL] [Abstract][Full Text] [Related]
38. Alpinetin inhibits LPS-induced inflammatory mediator response by activating PPAR-γ in THP-1-derived macrophages.
Hu K; Yang Y; Tu Q; Luo Y; Ma R
Eur J Pharmacol; 2013 Dec; 721(1-3):96-102. PubMed ID: 24104193
[TBL] [Abstract][Full Text] [Related]
39. Modulation of TNFalpha, IL-10 and IL-12p40 levels by a ceramide-1-phosphate analog, PCERA-1, in vivo and ex vivo in primary macrophages.
Avni D; Goldsmith M; Ernst O; Mashiach R; Tuntland T; Meijler MM; Gray NS; Rosen H; Zor T
Immunol Lett; 2009 Mar; 123(1):1-8. PubMed ID: 19185589
[TBL] [Abstract][Full Text] [Related]
40. MKP-1 promotes anti-inflammatory M(IL-4/IL-13) macrophage phenotype and mediates the anti-inflammatory effects of glucocorticoids.
Pemmari A; Paukkeri EL; Hämäläinen M; Leppänen T; Korhonen R; Moilanen E
Basic Clin Pharmacol Toxicol; 2019 Apr; 124(4):404-415. PubMed ID: 30388313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
